Deactivation of Pacemakers and Implantable Cardioverter-Defibrillators

Progress in Cardiovascular Diseases

Volumn 55, Issue 3, 2012, Pages 290-299

  Kramer, Daniel B ^a,b,c   Mitchell, Susan L ^a,b   Brock, Dan W ^b  

^a Hebrew SeniorLife Institute for Aging Research   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

End of life care; Ethics; Implantable cardioverter defibrillators; Pacemakers

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; DEVICE DEACTIVATION; DYING; FAMILY DECISION MAKING; HEALTH CARE PLANNING; HEART ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; PATIENT ATTITUDE; PATIENT AUTONOMY; PATIENT CARE; PATIENT DECISION MAKING; PATIENT RIGHT; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIVACY; SURGICAL TECHNIQUE; TERMINAL CARE; TREATMENT REFUSAL;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEALTH PERSONNEL; HUMANS; PACEMAKER, ARTIFICIAL; TERMINAL CARE; WITHHOLDING TREATMENT;

EID: 84870554187     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.09.003     Document Type: Article

References (55)

1. Nietzsche F.W., Kaufmann W.A. The gay science; with a prelude in rhymes and an appendix of songs 1974, Vintage Books, New York. 1st ed.
2. Hammill S.C., Kremers M.S., Stevenson L.W., et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm Sep 2010, 7(9):1340-1345.
3. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008, 117(21):e350-e408.
4. Hlatky M.A., Sanders G.D., Owens D.K. Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator. Health Aff (Millwood) 2005, 24(1):42-51.
5. Lamas G.A., Lee K.L., Sweeney M.O., et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002, 346(24):1854-1862.
6. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346(12):877-883.
7. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350(21):2140-2150.
8. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352(15):1539-1549.
9. Lampert R., Hayes D.L., Annas G.J., et al. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy This document was developed in collaboration with the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM); the American Heart Association (AHA), and the European Heart Rhythm Association (EHRA). Heart Rhythm 2010, 7(7):1008-1026.
10. Padeletti L., Arnar D.O., Boncinelli L., et al. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010, 12(10):1480-1489.
11. Russo J.E. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes. Am J Nurs 2011, 111(10):26-35.
12. Winter R.O., Birnberg B.A. Million dollar baby: murder or mercy. Fam Med 2009, 41(3):164-166.
13. Quill T.E. Terri Schiavo-a tragedy compounded. N Engl J Med 2005, 352(16):1630-1633.
14. Annas G.J. "Culture of life" politics at the bedside-the case of Terri Schiavo. N Engl J Med 2005, 352(16):1710-1715.
15. Annas G.J., Densberger J.E. Competence to refuse medical treatment: autonomy vs. paternalism. Univ Toledo Law Rev. Winter 1984, 15(2):561-596.
16. Pellegrino E.D. Decisions to withdraw life-sustaining treatment: a moral algorithm. JAMA 2000, 283(8):1065-1067.
17. Quill T.E., Barold S.S., Sussman B.L. Discontinuing an implantable cardioverter defibrillator as a life-sustaining treatment. Am J Cardiol 1994, 74(2):205-207.
18. Rhymes J.A., McCullough L.B., Luchi R.J., et al. Withdrawing very low-burden interventions in chronically ill patients. JAMA 2000, 283(8):1061-1063.
19. Bouvia v. Superior Court (Glenchur) (1986) 179 Cal. App. 3d 1127 [225 Cal. Rptr. 297].
20. Cruzan v. Director, Missouri Department of Health, 497 U.S. 261 (1990). 497; U.S. 261 88-1503. 1990. Supreme Court of the United States.
21. In re Quinlan, 70 N.J. 10, 355 A.2d 647 (1976). 70 N.J. 10, 355 A.2d 647. 1976. New Jersey Supreme Court.
22. Hook C.C., Mueller P.S. The Terri Schiavo saga: the making of a tragedy and lessons learned. Mayo Clin Proc Nov 2005, 80(11):1449-1460.
23. Sulmasy D.P. Within you/without you: biotechnology, ontology, and ethics. J Gen Intern Med 2008, 23(Suppl. 1):69-72.
24. Zellner R.A., Aulisio M.P., Lewis W.R. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminal illness. Patient autonomy is paramount. Circ Arrhythm Electrophysiol 2009, 2(3):340-344. [discussion 340].
25. Kramer DB, Kesselheim AS, Salberg L, et al. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2011;107(7):1071-1075 e1075.
26. Olsen M.L., Swetz K.M., Mueller P.S. Ethical decision making with end-of-life care: palliative sedation and withholding or withdrawing life-sustaining treatments. Mayo Clin Proc 2010, 85(10):949-954.
27. Quill T.E., Dresser R., Brock D.W. The rule of double effect-a critique of its role in end-of-life decision making. N Engl J Med 1997, 337(24):1768-1771.
28. Kramer D.B., Ottenberg A.L., Gerhardson S., et al. "Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators. J Interv Card Electrophysiol 2011, 32(3):243-252.
29. Goldstein N.E., Lampert R., Bradley E., et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004, 141(11):835-838.
30. Goldstein N., Carlson M., Livote E., et al. Brief communication: management of implantable cardioverter-defibrillators in hospice: a nationwide survey. Ann Intern Med 2010, 152(5):296-299.
31. Kobza R., Erne P. End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol 2007, 30(7):845-849.
32. Lewis W.R., Luebke D.L., Johnson N.J., et al. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 2006, 119(10):892-896.
33. Stewart G.C., Weintraub J.R., Pratibhu P.P., et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail 2010, 16(2):106-113.
34. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352(3):225-237.
35. Raphael C.E., Koa-Wing M., Stain N., et al. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?. Pacing Clin Electrophysiol 2011, 34(12):1628-1633.
36. Goldstein N.E., Mehta D., Teitelbaum E., et al. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med 2008, 23(Suppl. 1):2-6.
37. Goldstein N.E., Mehta D., Siddiqui S., et al. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008, 23(Suppl. 1):7-12.
38. Kramer D.B., Kesselheim A.S., Brock D.W., et al. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment. Heart Rhythm 2010, 7(11):1537-1542.
39. Kapa S., Mueller P.S., Hayes D.L., et al. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010, 85(11):981-990.
40. Mueller P.S., Jenkins S.M., Bramstedt K.A., et al. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol 2008, 31(5):560-568.
41. Mueller P.S., Ottenberg A.L., Hayes D.L., et al. "I felt like the angel of death": role conflicts and moral distress among allied professionals employed by the US cardiovascular implantable electronic device industry. J Interv Card Electrophysiol 2011, 32(3):253-261.
42. Goldstein N., Bradley E., Zeidman J., et al. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol 2009, 54(4):371-373.
43. Kelley AS, Reid MC, Miller DH, et al. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey. Am Heart J. 2009;157(4):702-708 e701.
44. Kelley A.S., Mehta S.S., Reid M.C. Management of patients with ICDs at the end of life (EOL): a qualitative study. Am J Hosp Palliat Care 2009/2008, 25(6):440-446.
45. Marinskis G., van Erven L. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey. Europace 2010, 12(8):1176-1177.
46. Hauptman P.J., Swindle J., Hussain Z., et al. Physician attitudes toward end-stage heart failure: a national survey. Am J Med 2008, 121(2):127-135.
47. Sherazi S., Daubert J.P., Block R.C., et al. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 2008, 83(10):1139-1141.
48. Tinetti M.E. The retreat from advanced care planning. JAMA 2012, 307(9):915-916.
49. Kamisar Y. Are the distinctions drawn in the debate about end-of-life decision making "principled"? If not, how much does it matter?. J Law Med Ethics 2012, 40(1):66-84.
50. Swetz K.M., Ottenberg A.L., Freeman M.R., et al. Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy. Curr Heart Fail Rep 2011, 8(3):212-218.
51. Swetz K.M., Mueller P.S., Ottenberg A.L., et al. The use of advance directives among patients with left ventricular assist devices. Hosp Pract (Minneap). 2011, 39(1):78-84.
52. Mueller P.S., Swetz K.M., Freeman M.R., et al. Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 2010, 85(9):791-797.
53. Kay G.N., Bittner G.T. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction. Circ Arrhythm Electrophysiol 2009, 2(3):336-339. [discussion 339].
54. Sweeney M.O. The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators. Circulation 2012, 126(3):369-377.
55. Nietzsche F.W., Hollingdale R.J., Nietzsche F.W. Twilight of the idols; and, The Anti-Christ 1968, Penguin, Harmondsworth.